Topic
8 articles
Brazil on Wednesday for the first time approved the use of a marijuana derivative to treat people suffering from epilepsy, multiple sclerosis and schizophrenia among other disorders. Directors of the country's Health Surveillance Agency recognized the therapeutic properties of cannabidiol...
Research from the University of Manchester sheds new light on the impact of marijuana use on schizophrenia. "There was no evidence of a specific association between cannabis use and positive symptoms, or negative symptoms, relapse or hospital admissions," wrote Christine Barrowclough, PhD.
Are concerns that marijuana increases the risk of schizophrenia valid? Matthew Hill, of Hotchkiss Brain Institute addressed the evidence behind the debate.
Dutch and British scientists say CBD in marijuana could be more effective than leading medications for psychotic disorders such as schizophrenia since...
A new Harvard study finds no evidence that marijuana causes schizophrenia.
The administration of the non-psychotropic plant constituent cannabidiol (CBD) is associated with a significant reduction in psychotic symptoms in patients with schizophrenia, according to clinical trial data published in the journal Translational…
A report from the National Center for Biotechnology Information finds Cannabidiolic acid inhibits MDA-MB-231, a powerful human breast cancer cell.
A scientific review: has found “There is now clear evidence that cannabinoids are useful for the treatment of various medical conditions.”
